Ratos: Ratos owns 22.5% of Lindab

Ratos: Ratos owns 22.5% of LindabThe over-allotment option granted by Ratos in connection with the Lindab IPO has now been exercised. Taking into account the shares sold in the offering and the shares sold pursuant to the over-allotment option, Ratos has sold 51% of its original holding in Lindab at a price corresponding to SEK 110 per share, and now owns 22.5% of the outstanding Lindab shares. Based on the consolidated value of Ratos's holding as of 30 September 2006, the exit gain from the sales is expected to be approx. SEK 1,500m. The final exit gain will be adjusted for Ratos's share of Lindab's profit until the date of the sale and potential exchange differences, and will be included in Ratos's Q4 result 2006. The consolidated book value of Ratos's remaining holding of 17.7 million shares will be approx. SEK 470m, based on the consolidated value as of 30 September. For further information regarding the Lindab IPO, please visit www.lindab.com/default.htm For further information, please contact:Arne Karlsson, CEO Ratos, +46 8 700 17 00Anna-Karin Celsing, Head of Corporate Communications Ratos, +46 70 399 62 39 Financial calendar from Ratos: Year-end report 2006 22 February 2007Annual General Meeting 11 April 2007Interim report January-March 9 May 2007Interim report January-June 21 August 2007 Interim report January-September 9 November 2007 Ratos is a listed private equity company. The business concept is to maximise shareholder value over time by investing in, developing and divesting primarily unlisted companies. Ratos thus offers stock market players a unique investment opportunity. The equity of Ratos's investments is approximately SEK 9 billion. Ratos's holdings include Alimak Hek, Arcus, Anticimex, Bisnode, Bluegarden, Camfil, DIAB, GS-Hydro, Haendig, Haglöfs, HL Display, Hägglunds Drives, Inwido, Jøtul, Lindab, Medifiq Healthcare, Superfos and Other holdings.Attachment: Press release (PDF)Text version / Internet version / Print / Close